• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Ghaith, A., El Hofy, A., Elfiky, S., Abdellatif, A. (2023). EVALUATION OF TREATMENT MODALITIES OF FUSARIUM FUNGAL KERATITIS. ALEXMED ePosters, 5(2), 16-17. doi: 10.21608/alexpo.2023.212349.1611
Alaa Atef Ghaith; Abd El Hamid Shaker El Hofy; Suzan Ahmed Mostafa Elfiky; Ahmed Salem Abdellatif. "EVALUATION OF TREATMENT MODALITIES OF FUSARIUM FUNGAL KERATITIS". ALEXMED ePosters, 5, 2, 2023, 16-17. doi: 10.21608/alexpo.2023.212349.1611
Ghaith, A., El Hofy, A., Elfiky, S., Abdellatif, A. (2023). 'EVALUATION OF TREATMENT MODALITIES OF FUSARIUM FUNGAL KERATITIS', ALEXMED ePosters, 5(2), pp. 16-17. doi: 10.21608/alexpo.2023.212349.1611
Ghaith, A., El Hofy, A., Elfiky, S., Abdellatif, A. EVALUATION OF TREATMENT MODALITIES OF FUSARIUM FUNGAL KERATITIS. ALEXMED ePosters, 2023; 5(2): 16-17. doi: 10.21608/alexpo.2023.212349.1611

EVALUATION OF TREATMENT MODALITIES OF FUSARIUM FUNGAL KERATITIS

Article 1, Volume 5, Issue 2, April 2023, Page 16-17  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2023.212349.1611
View on SCiNiTO View on SCiNiTO
Authors
Alaa Atef Ghaith1; Abd El Hamid Shaker El Hofy1; Suzan Ahmed Mostafa Elfiky2; Ahmed Salem Abdellatif email 3
1Department of ophthalmology, faculty of medicine, Alexandria university, Alexandria ,Egypt
2Department of Microbiology, Faculty of Medicine, University of Alexandria
3Department of Ophthalmology, Faculty of Medicine, University of Alexandria
Abstract
Infection of the cornea by filamentous fungus and yeasts, often known as keratomycosis or fungal keratitis, is common. This illness may pose a harm to the eyes. The prevalence of different causes varies according on where people are from. The weather is also a major role. Filamentous fungi are more common in tropical and subtropical areas, whereas yeasts are thought to predominate in temperate zones.
The most common individual risk factors for FK include trauma, immunes uppression, ocular surface disease, and contact lens usage, any or all of which might increase susceptibility to a fungal infection
A fungal infection as a cause of keratitis may be difficult to identify clinically, and delays in diagnosis are frequent due to negative or delayed culture findings
Topical anti-fungal medicines are the mainstay of pharmacological therapy for fungal keratitis. No antifungal recommendations based on individual fungal isolation are presently available. Many of these anti-fungal treatments have varying degrees of corneal penetration activity or efficacy. The most effective method of therapy is still the use of pharmacologically active antimicrobials via a topical application. Intra-stromal injections have been controversial since they have not been found to be more effective than topical instillation.
Keywords
FUSARIUM; FUNGAL KERATITIS; TREATMENT
Supplementary Files
download 1611 20 (9).pdf
Statistics
Article View: 67
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.